The American Society of Clinical Oncology meeting, the world's biggest cancer conference, has kicked off in blazing sunshine and amid much anticipation in Chicago.
AbbVie/Roche's Venclexta (venetoclax) has produced a high overall response rate in chronic lymphocytic leukaemia patients with the 17p deletion mutation, a sub-group who do not respond well
New technologies and new business models are transforming life science companies. A new book from Accenture maps out the fresh approaches being taken across healthcare.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
